CLINICAL_TRIALS
trial_result
· 2017-03-31
Clinical Trial Update: Insulin Resistance in Pulmonary Arterial Hypertension [Phase 2]
Summary
A Phase 2 trial investigating insulin resistance in pulmonary arterial hypertension was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stanford University | Conditions: Hypertension, Pulmonary | Phase 2 | Status: TERMINATED | Results posted: 2017-03-31